Henderson Michael Thomas's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Sep 3, 2026
- Accession no.
- 0001140361-26-035609
- Filed
- Sep 3, 2026, 4:39 PM ET
- Trade date
- Sep 3, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 3 derivative transactions. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson Michael ThomasCIK 0001779990 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | DReturned to the companyDisposed | −920,941 | – | – | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | DReturned to the companyDisposed | −387,012 | – | – | 0 | Direct | |
| Sep 3, 2026 | Common Stock | DReturned to the companyDisposed | −357,036 | – | – | 0 | Direct | |
| Sep 3, 2026 | Common Stock | DReturned to the companyDisposed | −253,016 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.